NCT05861414 is a NA clinical trial of EWM-T in Depressive Symptoms, sponsored by Yu-hua Weng.

Who is sponsoring NCT05861414?

NCT05861414 is sponsored by Yu-hua Weng.

What drugs are being tested in NCT05861414?

Interventions in NCT05861414: EWM-T.

What condition does NCT05861414 study?

NCT05861414 studies Depressive Symptoms.

Is NCT05861414 still recruiting?

NCT05861414 is currently completed. Last updated 16 May 2023.

Last reviewed 2023-05-16 · How we verify

NCT05861414

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intervention Effect of Emotional Working Memory Training on University Students With Depressive Symptom

Completed NA Last updated 16 May 2023

What this trial tests

NA trial testing EWM-T in Depressive Symptoms in 50 participants. Completed in 21 March 2023.

Timeline

11 October 2022

Primary endpoint
11 November 2022

21 March 2023

Quick facts

Lead sponsor	Yu-hua Weng
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	11 October 2022
Primary completion	11 November 2022
Estimated completion	21 March 2023
Sites	1 location across China

Drugs / interventions tested

EWM-T

Conditions studied

Depressive Symptoms — all drugs for Depressive Symptoms →

Sponsor

Yu-hua Weng

Who can join

Eligibility, any sex, with Depressive Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: To investigate the effects of emotional working memory training (EWM-T) on depressive symptoms and rumination among university students. Methods: The experimental group comprised 25 participants who underwent 21 days of emotional working memory training, which involved viewing a continuous stream of negative emotional face content on a grid and remembering the faces and locations presented on the grid. The control group consisted of 25 participants. The Beck Depression Inventory-II (BDI-II), the Chinese version of the Character-Digital Breadth Test, and the Ruminative Responses Scale (RRS) were used as the pre- and post-test indicators.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Depressive Symptoms

Currently open trials in the same condition.

NCT07299903 — IMB-Based Sleep Hygiene Education for Menopausal Women: Effects on Sleep Quality and Depression · NA · recruiting
NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
NCT07241325 — Psychological Well-Being, Depression, and Health-Related Quality of Life in Adults With Type 2 Diabetes: A Cross-Section · recruiting
NCT07216326 — Our Voices Matter: Intervention for Depression in Youth · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05861414 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yu-hua Weng
Last refreshed: 16 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05861414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing